Wasdom Pharmchem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 26.75%
- Profit Growth 568.70%
- Ebitda 415.46%
- Net Worth 16.16%
- Total Assets -21.12%
About Wasdom Pharmchem
Wasdom Pharmchem Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 July 2011 and has a history of 13 years and seven months. Its registered office is in Chandigarh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Deepti Sharma and Himanshu Khandelwal serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232CH2011PTC033088
-
Company No.
033088
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jul 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Wasdom Pharmchem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Khandelwal
|
Managing Director | 05-Jul-2011 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Deepti Sharma
|
Director | 05-Jul-2011 | Current |
Financial Performance of Wasdom Pharmchem.
Wasdom Pharmchem Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 26.75% increase. The company also saw a substantial improvement in profitability, with a 568.7% increase in profit. The company's net worth Soared by an impressive increase of 16.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wasdom Pharmchem?
In 2017, Wasdom Pharmchem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Satva Body Brain Fuel Private LimitedHimanshu Khandelwal is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Feb 2018 | Others | ₹1.00 M | Open |
How Many Employees Work at Wasdom Pharmchem?
Unlock and access historical data on people associated with Wasdom Pharmchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wasdom Pharmchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wasdom Pharmchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.